Market research firm SNS Insider has published new research findings on the Robotic Endoscopy Devices Market. According to their estimates, the global market size is projected to expand from US$2.85 billion in 2025 to US$8.24 billion in 2035, with a compound annual growth rate (CAGR) of 11.20% from 2026 to 2035. Growing interest in the early diagnosis of gastrointestinal and pulmonary diseases, along with the development of robotic technology that supports minimally invasive examinations and treatments, are driving the market's growth.
Robotic endoscopy devices are medical devices that assist in the operation and positioning of endoscopes within the body and access to complex anatomical structures. By combining robotic control, imaging technology, and navigation functions, they assist physicians in diagnosis and treatment. Research and development of related technologies is particularly progressing in areas where precise location confirmation is necessary, such as lesions in the gastrointestinal tract and nodules located in the periphery of the lungs.
Download a free sample of the research report on the robot-assisted endoscopy equipment market:
https://www.snsinsider.com/sample-request/10799
The demand for minimally invasive diagnosis is driving the development of robot-assisted endoscopy technology
. In examinations using gastrointestinal endoscopes and bronchoscopes, the location of the lesion and the anatomical characteristics of the patient can make it difficult to operate the equipment. To address these challenges, technologies that support the stabilization and precise guidance of endoscopes through robotic control are attracting attention.
Robot-assisted endoscopy systems aim to provide assistance to physicians in controlling the direction and position of the endoscope, and to support examinations of areas that are difficult to access with conventional manual operation. However, not all procedures will yield better results than conventional endoscopes, and clinical usefulness varies depending on the target disease, equipment performance, and the experience of the medical professional.
In addition to addressing aging and chronic diseases, improving the efficiency of examinations in medical institutions is also an important theme. In the future, technological development including operability, image quality, and suitability to the examination process is expected to influence the competitive environment of the related market.
Robot-assisted therapeutic endoscopic systems to capture 58.20% of the market share in 2025
According to an analysis by SNS Insider, robot-assisted therapeutic endoscopic systems will account for approximately 58.20% of the sales share in the product-based market in 2025, making them the largest segment. Therapeutic systems support procedures such as tissue sampling and lesion resection using endoscopes, playing a crucial role in medical institutions that require specialized therapeutic functions.
Meanwhile, robot-assisted diagnostic endoscopic systems are projected to grow at an average annual rate of 13.60% from 2026 to 2035, representing the highest growth rate among all product segments. As the development of examination systems for the early detection of cancers such as colorectal cancer and lung cancer progresses, interest in navigation functions and high-resolution imaging technology that support precise diagnosis is increasing.
By component and service segment, the robot system itself will account for approximately 47.60% of the sales share in 2025. On the other hand, the software and services segment is projected to grow at an average annual rate of 15.30%. Software updates, maintenance, operation training, and utilization of examination data after equipment installation are important elements that support the operation of medical institutions.
Gastrointestinal endoscopy accounts for 42.30% of the market,
while the bronchoscopy sector is projected to see high growth. By application, gastrointestinal endoscopy will account for approximately 42.30% of the market share in 2025, making it the largest sector. In the diagnosis and treatment of gastrointestinal lesions, it is necessary to appropriately evaluate the location and size of the lesion and the patient's condition. Technologies that support advanced endoscopic operations are an important research and development area for medical facilities that handle specialized procedures.
On the other hand, the bronchoscopy sector is projected to grow at an average annual rate of 14.20% from 2026 to 2035, with the highest growth rate expected among all application sectors. In the evaluation of peripheral lung nodules discovered during lung cancer screening, there is growing demand for technologies that guide the endoscope to the target location.
By end-user, hospitals accounted for approximately 68.50% of the market share in 2025. Meanwhile, outpatient surgery centers are projected to grow at an average annual rate of 14.60%. In medical institutions, it is important to select an appropriate clinical environment according to the patient's condition and the procedure, and the installation space and operating costs of the equipment also influence the decision to introduce it.
See detailed market forecasts and competitive landscape for the robotic-assisted endoscopy devices market:
https://www.snsinsider.com/reports/robotic-endoscopy-devices-market-10799
US Robotic-Assisted Endoscopy Devices Market to Reach US$2.52 Billion by 2035
According to SNS Insider, the US robotic-assisted endoscopy devices market is projected to reach US$2.52 billion by 2035, up from US$880 million in 2025, growing at a compound annual rate of 11.10% from 2026 to 2035.
In the US, the presence of hospitals and specialized medical institutions adopting advanced endoscopic diagnostic technologies supports the market. In particular, robotic-assisted bronchoscopes that help reach peripheral lesions in the lungs and technologies that support complex procedures in the gastrointestinal field are attracting attention.
R&D investments by medical device manufacturers and capital investments in minimally invasive diagnostics by medical institutions are also important demand drivers. On the other hand, since the introduction of equipment requires purchase costs, training for doctors and staff, and maintenance contracts, medical facilities need to compare the clinical benefits with the total cost of ownership.
In the future, factors such as the operability of robotic systems, navigation accuracy, integration with imaging technology, and eligibility requirements under the medical insurance system are expected to influence market trends.
The North American market will become the largest
in the world by 2025, accounting for 36.50% of sales. According to SNS Insider's regional analysis, the United States accounts for approximately 85.00% of the North American market, making it the major demand country.
In North America, the presence of hospitals and research institutions capable of introducing advanced medical equipment, as well as interest in cancer screening and endoscopic diagnostic technologies, supports the market. Research and development of technologies for minimally invasive procedures is progressing in clinical areas such as gastroenterology, respiratory medicine, and urology.
In Canada, as medical facilities are modernized and specialized medical systems are being developed, advanced endoscopic technology is being considered. Across North America, important business areas for medical device manufacturers include not only the introduction of new equipment, but also related software updates, maintenance services, and training for healthcare professionals. In
the European market, Germany accounts for 28.00%, and investment in precision diagnostic technology continues.
The European robot-assisted endoscopy market is expected to see demand driven by investment in minimally invasive diagnostic technology in healthcare institutions and the development of medical systems for early cancer diagnosis. According to an analysis by SNS Insider, Germany will account for approximately 28.00% of the European market in 2025, becoming the major country market.
In Germany, the technological base of the medical device industry and the presence of highly specialized medical facilities support interest in advanced endoscopic equipment. In the UK, France, Italy, and other countries, the advancement of diagnostic systems for gastrointestinal and respiratory diseases is also a key issue.
In Europe, capital investment is required that takes into account compliance with medical device regulations, product safety, clinical performance, and the operational burden on healthcare institutions. In the future, in addition to the development of diagnostic equipment that combines robot control and image analysis technology, post-implementation training and continuous maintenance systems are also expected to become competitive factors.
The Asia Pacific market is projected to grow at an average annual rate of 13.80%, with Japan focusing on advanced endoscopic technology.
The Asia Pacific region is projected to grow at an average annual rate of 13.80% from 2026 to 2035, making it the highest growth rate in the world. By 2025, China will account for approximately 24.00% of the regional market, with investment in medical equipment and the development of medical robot-related technologies influencing the market environment.
In countries such as China and India, the expansion of medical facilities and improved access to endoscopic diagnosis may lead to new opportunities for the introduction of robot-assisted technologies. Meanwhile, Japan, as a market with a foundation in gastrointestinal endoscopy technology and medical device development, is focusing on research and development that combines precise endoscopic operation with advanced imaging technology.
In Japanese medical institutions, appropriate access to lesions, accuracy of specimen collection, patient safety, and efficiency of the examination process are important in the diagnosis of gastrointestinal and respiratory diseases. Endoscopic devices equipped with robot-assisted functions are one technical option to address these challenges.
For domestic medical device manufacturers and related technology companies, areas of research and development and business development include robot control technology, high-definition imaging systems, endoscopic instruments, and navigation software.
However, the 13.80% growth rate is a forecast for the entire Asia-Pacific region and does not represent the growth rate for Japan alone.
AI navigation and image analysis technology are the focus of next-generation endoscope development.
In the technological development of robot-assisted endoscopes, position confirmation using image information and navigation functions that support the movement path of the equipment are important. In particular, when evaluating small nodules located in the periphery of the lungs, the reachability and position confirmation of the endoscope are important challenges in the examination.
Image analysis technology using artificial intelligence (AI) has the potential to support the detection of candidate lesions and the organization of examination data. Research and development is also underway to assist physicians in endoscopic operation by combining robot control technology and imaging systems. On the other hand
, the diagnostic performance and clinical usefulness of these systems differ from product to product, and a definitive diagnosis cannot be made by AI analysis alone. Medical institutions are required to confirm relevant clinical data, regulatory approval scope, and suitability for the examination purpose. With
increasing interest in disposable parts and operational management technologies
, infection control and equipment reprocessing are also important considerations in the operation of endoscopic equipment. Reusable endoscopes and related instruments require appropriate cleaning, disinfection, and sterilization processes specified by the manufacturer.
Against this backdrop, interest in disposable endoscopic parts and single-use related equipment is growing. However, disposable products also present challenges such as waste and procurement costs, so healthcare institutions need to comprehensively evaluate infection control requirements and operational costs.
Furthermore, software updates, equipment calibration, training for medical personnel, and management of equipment operational status are also important for the continuous use of robot-assisted endoscopy technology.
Capital investment and securing specialized personnel are challenges to widespread adoption .
While advanced robot-assisted endoscopy systems have the potential to become important diagnostic and treatment equipment for healthcare institutions, their introduction requires a considerable capital investment. Operational costs include not only purchase costs but also preparation of the installation environment, specialized equipment, maintenance contracts, software updates, and training for doctors and nursing staff.
Healthcare institutions need to consider factors such as the annual number of examinations, target diseases, and compatibility with existing endoscopic equipment when deciding whether to introduce such systems. Small and medium-sized facilities, in particular, need to thoroughly evaluate the cost-effectiveness of the equipment.
Going forward, compact device design, improved operability, and continuous technical support will be crucial when considering adoption in a wider range of medical environments. The global robot
-assisted endoscopy market involves companies such
as Intuitive Surgical, Medtronic, Boston Scientific, Olympus, Johnson &Johnson MedTech, Noah Medical, EndoQuest Robotics, and EndoMaster. FUJIFILM, PENTAX Medical (a subsidiary of HOYA), and KARL STORZ also operate in the fields of endoscopy-related equipment and medical technology.
These companies differ in their product portfolios, stages of technology development, and regulatory approval status. In the future, precise endoscopic manipulation by robots, access to complex anatomical areas, integration with image analysis technology, and support for implementation in medical institutions are expected to be key areas of competition.
In particular, the development of products tailored to specific clinical applications, such as diagnostic robot-assisted bronchoscopes and therapeutic endoscopy systems, represents a significant business opportunity for medical device manufacturers and related technology suppliers.
Regarding the research report
, SNS Insider's "Robotic Endoscopy Devices Market" report analyzes the market size and growth prospects up to 2035, using 2025 as the base year.
The report analyzes robotic-assisted therapeutic endoscopic systems and robotic-assisted diagnostic endoscopic systems by product, and by component, it covers robotic systems, instruments and accessories, and software and services.
By application, it covers gastrointestinal endoscopy, bronchoscopy, urology, gynecology, etc., and by end-user, it examines demand trends in hospitals, outpatient surgery centers, and specialized clinics. By region, it provides information on market growth drivers, competitive landscape, technological trends, and future business opportunities for North America, Europe, Asia Pacific (including Japan), the Middle East and Africa, and Latin America. Other market research reports
include: Vaccine Delivery Devices Market https://www.linkedin.com/pulse/vaccine-delivery-devices-market-report-syringes-patches-mayur-pande-eh8tf/ and Enterprise Imaging Solutions Market https://www.linkedin.com/pulse/enterprise-imaging-solutions-market-size-report-pacs-cloud-pande-44npf/
配信元企業：SNS INSIDER PVT. LTD.
プレスリリース詳細へ
ドリームニューストップへ
